Evidence map›Paper›PMID 32639615›Full record

ArticleCancer2020

The 3 Bs of cancer care amid the COVID-19 pandemic crisis: "Be safe, be smart, be kind"-A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer.

Jung Julie Kang, Richard J Wong, Eric J Sherman, Alisa Rybkin, Sean M McBride, Nadeem Riaz, C Jillian Tsai, Yao Yu, Linda Chen, Kaveh Zakeri and 17 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Radiotherapy during the COVID-19: a review about management and treatment strategies.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2022
    Article
  14. Review
  15. The role of teledentistry in oral cancer patients during the COVID-19 pandemic: an integrative literature review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Review
  16. Article
  17. Article
  18. Making the Best of Limited Resources: Improving Outcomes in Head and Neck Cancer.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2021
    Article
  19. Impact of Telemedicine on Patient Satisfaction and Perceptions of Care Quality in Radiation Oncology.Journal of the National Comprehensive Cancer Network : JNCCN · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 1 institution in 1 country.

Jung Julie KangDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0001-9773-5481
Richard J WongDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Eric J ShermanDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-4960-4783
Alisa RybkinDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Sean M McBrideDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Nadeem RiazDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
C Jillian TsaiDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Yao YuDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Linda ChenDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Kaveh ZakeriDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0003-3921-480X
Daphna Y GelblumDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Erin F GillespieDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Marc A CohenDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Jennifer R CracchioloDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0003-4496-906X
Ian GanlyDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Snehal PatelDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0001-9775-5132
Bhuvanesh SinghDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Jay O BoyleDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Benjamin R RomanDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Luc G MorrisDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-4417-2280
Ashok R ShahaDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Lara A DunnDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Alan L HoDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
James V FettenDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Jatin P ShahDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
David G PfisterDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Nancy Y LeeDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Memorial Sloan Kettering Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Because of the national emergency triggered by the coronavirus disease 2019 (COVID-19) pandemic, government-mandated public health directives have drastically changed not only social norms but also the practice of oncologic medicine. Timely head and neck cancer (HNC) treatment must be prioritized, even during emergencies. Because severe acute respiratory syndrome coronavirus 2 predominantly resides in the sinonasal/oral/oropharyngeal tracts, nonessential mucosal procedures are restricted, and HNCs are being triaged toward nonsurgical treatments when cures are comparable. Consequently, radiation utilization will likely increase during this pandemic. Even in radiation oncology, standard in-person and endoscopic evaluations are being restrained to limit exposure risks and preserve personal protective equipment for other frontline workers. The authors have implemented telemedicine and multidisciplinary conferences to continue to offer standard-of-care HNC treatments during this uniquely challenging time. Because of the lack of feasibility data on telemedicine for HNC, they report their early experience at a high-volume cancer center at the domestic epicenter of the COVID-19 crisis.

Indexed as

COVID-19Elective Surgical ProceduresHead and Neck NeoplasmsHumansPersonal Protective EquipmentPractice Guidelines as TopicRadiation OncologyTelemedicinecoronavirus disease 2019 (COVID-19)head and neck cancerradiation oncologytelehealthtelemedicine

Identifiers

PMID32639615
PMCPMC7361524
OpenAlexW3042204515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.